(Total Views: 702)
Posted On: 09/30/2020 8:07:05 PM
Post# of 149993
Appears CyDy has registered CD12 in the EU:
https://www.clinicaltrialsregister.eu/ctr-sea...Leronlimab
1 result(s) found for: Leronlimab. Displaying page 1 of 1.
EudraCT Number: 2020-001996-33 Sponsor Protocol Number: CD12_COVID-19 Start Date*: 2020-08-26
Sponsor Name:CytoDyn, Inc.
Full Title: A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (CO...
Medical condition: Coronavirus Disease 2019 (COVID-19)
Disease: Version SOC Term Classification Code Term Level
23.0 100000004862 10053983 Corona virus infection LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing)
Trial results: (No results available)
https://www.clinicaltrialsregister.eu/ctr-sea...Leronlimab
1 result(s) found for: Leronlimab. Displaying page 1 of 1.
EudraCT Number: 2020-001996-33 Sponsor Protocol Number: CD12_COVID-19 Start Date*: 2020-08-26
Sponsor Name:CytoDyn, Inc.
Full Title: A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (CO...
Medical condition: Coronavirus Disease 2019 (COVID-19)
Disease: Version SOC Term Classification Code Term Level
23.0 100000004862 10053983 Corona virus infection LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing)
Trial results: (No results available)
(3)
(0)Scroll down for more posts ▼
